December 26, 2017 8:09am
Not much … make tracks with your laggards, especially those with a financing due
My coming view: volatility and turbulence should cause an upsurge of risk exposure in sector equities, only news will set them free – if then, as all we have seen is selling into events, lately
Out and about: ODD how Biostage (BSTG) reversed split (1-for-20) just before a holiday – thinking current investors couldn’t contest it - https://www.regmedinvestors.com/articles/10059
Lower open expected
Dow futures are DOWN -0.22% (-55 points) and NASDAQ futures are DOWN -0.52% (-33.75points)
U.S. stocks on Tuesday were set for a slightly weaker open as investors returned from the long holiday break.
European markets are closed Tuesday in observance of Boxing Day.
Asian indexes closed mixed on Tuesday after a session of light, holiday-week trading in most markets.
Issues that will affect the trading day: In a holiday shortened week, with most global markets closed on Monday, volumes may stay low given many traders may stay away until after New Year.
Data docket: Case-Shiller home prices are coming at 9 a.m. Eastern Time, in what will be a fairly subdued week for data.
Issues on the political front: The mimosas at Mar-a Lago
Henry’omics:
From last Tuesday night’s closing bell post, it was a "whacky" week ... patience should be a by-word - let the year end and go away.”
What’s for the week – clean-up, be careful of what ails your portfolio – it might be time to DUMP the consistent laggards and those who have a financing in the “cards”, you are holding!
Although trading is expected to be thin this week - as many traders are still away for the Christmas break.
I DON’T foresee ANY miracles in this dead week …
The RegMed, stem and cell therapy sector’s record over 5 sessions (of 40 covered companies):
The RegMed and cell therapy sector was closed on Monday, NEGATIVE on Friday, POSITIVE on Thursday and Wednesday and closed NEGATIVE on last Tuesday;
· Monday was Christmas Day;
· Friday closed NEGATIVE with 19 decliners, 18 advancers and 3 flats
· Thursday closed POSITIVE with 18 decliners, 20 advancers and 2 flats;
· Wednesday closed POSITIVE with 18 decliners, 19 advancers and 3 flat;
· Last Tuesday closed NEGATIVE with 27 decliners, 11 advancers and 2 flats;
Today’s indications:
The iShares Nasdaq Biotechnology (IBB) is NOT indicating Tuesday’s pre-market;
The SPDR S&P Biotech ETF (XBI) is NOT indicating in Tuesday’s pre-market;
The Health Care Select Sector SPDR ETF (XLV) is NOT indicating in Tuesday’s pre-open;
The iShares Russell 2000 (IWM) is indicating a NEGATIVE -0.15% in Tuesday’s pre-open
Companies in my headlights:
Reiterating, “There is just NO impetus (direction) share price change …or news for sector stocks other than pure speculation that will dissipate any upside in a sell order!”
Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice.
Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors. All investments are subject to risks. Investors should consider investment objectives.
